MBOAT7
Basic information
Region (hg38): 19:54173412-54189882
Previous symbols: [ "LENG4" ]
Links
Phenotypes
GenCC
Source:
- intellectual disability, autosomal recessive 57 (Moderate), mode of inheritance: AR
- intellectual disability, autosomal recessive 57 (Strong), mode of inheritance: AR
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
- intellectual disability, autosomal recessive 57 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder, autosomal recessive 57 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 27616480 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (106 variants)
- not_provided (41 variants)
- Intellectual_disability,_autosomal_recessive_57 (40 variants)
- MBOAT7-related_disorder (12 variants)
- not_specified (4 variants)
- Intellectual_disability (3 variants)
- Neurodevelopmental_abnormality (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MBOAT7 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000024298.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 22 | 23 | ||||
missense | 115 | 120 | ||||
nonsense | 6 | |||||
start loss | 2 | 2 | ||||
frameshift | 18 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
Total | 12 | 14 | 122 | 25 | 0 |
Highest pathogenic variant AF is 0.000052546413
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MBOAT7 | protein_coding | protein_coding | ENST00000245615 | 7 | 16627 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.113 | 0.886 | 125731 | 0 | 15 | 125746 | 0.0000596 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.441 | 274 | 295 | 0.928 | 0.0000203 | 2959 |
Missense in Polyphen | 74 | 92.4 | 0.80087 | 959 | ||
Synonymous | -1.51 | 156 | 134 | 1.17 | 0.00000949 | 1020 |
Loss of Function | 2.85 | 5 | 18.1 | 0.276 | 8.58e-7 | 199 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000369 | 0.000365 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000513 | 0.0000462 |
European (Non-Finnish) | 0.0000484 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acyltransferase which contributes to the regulation of free arachidonic acid (AA) in the cell through the remodeling of phospholipids. Mediates the conversion of lysophosphatidylinositol (1-acylglycerophosphatidylinositol or LPI) into phosphatidylinositol (1,2-diacyl-sn-glycero-3-phosphoinositol or PI) (LPIAT activity). Prefers arachidonoyl-CoA as the acyl donor. Lysophospholipid acyltransferases (LPLATs) catalyze the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle. Required for cortical lamination during brain development (By similarity). {ECO:0000250|UniProtKB:Q8CHK3, ECO:0000269|PubMed:18094042, ECO:0000269|PubMed:18772128}.;
- Pathway
- Glycerophospholipid metabolism - Homo sapiens (human);Acyl chain remodelling of PI;Metabolism of lipids;Metabolism;CDP-diacylglycerol biosynthesis;triacylglycerol biosynthesis;Glycerophospholipid biosynthesis;Phospholipid metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.690
- rvis_EVS
- -0.53
- rvis_percentile_EVS
- 20.7
Haploinsufficiency Scores
- pHI
- 0.180
- hipred
- N
- hipred_score
- 0.267
- ghis
- 0.514
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.283
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mboat7
- Phenotype
- craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;
Gene ontology
- Biological process
- phospholipid biosynthetic process;ventricular system development;layer formation in cerebral cortex;phosphatidylinositol acyl-chain remodeling
- Cellular component
- endoplasmic reticulum membrane;membrane;integral component of membrane
- Molecular function
- 1-acylglycerol-3-phosphate O-acyltransferase activity;protein binding;2-acylglycerol-3-phosphate O-acyltransferase activity;lysophospholipid acyltransferase activity